INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
SP

Siegrist Jonathan Philip

EVP of R&D & CTOCIK 0002040321

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 0
Max Insider Score21
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Option exercise
M—
18.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    QuidelOrtho CorpEVP of R&D & CTO · Feb 2, 2026
20
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Tax withholding
F
$93K
6,695 sh
Oct 15, 2026
Oct 19, 2026
traded Oct 15, 2026
+4d
SEC FORM 4

Evidence

9
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Option exercise
M—
18.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

9
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Grant or award
A—
36.2K sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC FORM 4

Evidence

9
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Grant or award
A—
36.1K sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC FORM 4

Evidence

21
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Option exercise
M—
2,448 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

17
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Grant or award
A—
2,448 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

13
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Tax withholding
F$28K
1,009 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence